Progress in vaccines for sexually transmitted diseases.
The development pipeline for vaccines to control sexually transmitted infections holds greater promise than ever before. Preclinical studies are encouraging in the development of chlamydia and gonococcal vaccines, and for the first time, recent clinical trials have shown the feasibility of creating vaccines to control genital herpes and cervical human papillomavirus infections. Behavioral research suggests that these vaccines will likely find acceptance among health care providers and consumers.
Stanberry
Lawrence R
LR
Department of Pediatrics and the Sealy Center for Vaccine Development, University of Texas Medical Branch, Children's Hospital, 301 University Boulevard, Galveston, TX 77555, USA. l.stanberry@utmb.edu
Rosenthal
Susan L
SL
D015195:Drug Design; D006801:Humans; D012749:Sexually Transmitted Diseases / Q000517:prevention & control*; D014765:Viral Vaccines / Q000627:therapeutic use*
D014765:Viral Vaccines